AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 150 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,534,000 | +26.7% | 116,506 | -3.7% | 0.00% | +33.3% |
| Q4 2018 | $4,369,000 | -71.3% | 121,031 | -51.1% | 0.00% | -40.0% |
| Q3 2018 | $15,230,000 | +166.2% | 247,428 | +192.1% | 0.01% | +25.0% |
| Q2 2018 | $5,721,000 | +16.7% | 84,700 | -6.3% | 0.00% | +33.3% |
| Q1 2018 | $4,904,000 | -8.2% | 90,392 | +1.1% | 0.00% | -25.0% |
| Q4 2017 | $5,341,000 | +9.5% | 89,396 | -11.0% | 0.00% | +33.3% |
| Q3 2017 | $4,879,000 | -25.3% | 100,397 | -19.2% | 0.00% | -40.0% |
| Q2 2017 | $6,529,000 | +25.8% | 124,238 | +8.5% | 0.01% | +25.0% |
| Q1 2017 | $5,191,000 | +13.6% | 114,457 | -5.2% | 0.00% | +33.3% |
| Q4 2016 | $4,570,000 | +7.0% | 120,746 | +6.7% | 0.00% | 0.0% |
| Q3 2016 | $4,273,000 | +137.0% | 113,215 | +10.5% | 0.00% | +200.0% |
| Q2 2016 | $1,803,000 | +45.8% | 102,456 | +0.7% | 0.00% | 0.0% |
| Q1 2016 | $1,237,000 | -51.1% | 101,709 | -2.1% | 0.00% | -50.0% |
| Q4 2015 | $2,530,000 | +29.0% | 103,899 | -6.0% | 0.00% | 0.0% |
| Q3 2015 | $1,961,000 | +24.9% | 110,518 | +24.3% | 0.00% | +100.0% |
| Q2 2015 | $1,570,000 | +25.3% | 88,941 | +122.5% | 0.00% | 0.0% |
| Q1 2015 | $1,253,000 | +2.8% | 39,982 | -4.3% | 0.00% | 0.0% |
| Q4 2014 | $1,219,000 | +32.5% | 41,761 | -6.1% | 0.00% | 0.0% |
| Q3 2014 | $920,000 | -1.7% | 44,469 | +17.7% | 0.00% | 0.0% |
| Q2 2014 | $936,000 | +70.2% | 37,769 | +45.4% | 0.00% | – |
| Q1 2014 | $550,000 | +52.8% | 25,969 | +29.4% | 0.00% | – |
| Q4 2013 | $360,000 | – | 20,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |